Document is current
Any future updates will be listed below
-
Authors
Hafezi, Farhad https://orcid.org/0000-0001-8935-4558
Messerli, Jürg
Torres-Netto, Emilio A.
Lu, Nan-Ji
Aydemir, M. Enes
Hafezi, Nikki L.
Hillen, Mark
-
Funding
Funding for this research was provided by:
Light for Sight Foundation
- License Information
-
More Information
Article History
Received: 9 July 2024
Accepted: 27 November 2024
First Online: 3 January 2025
Declarations
:
: This procedure was performed under compassionate use conditions as permitted by the Kanton Zurich Kantonal Ethikkommission.
: Informed consent for publication was obtained from the patient.
: Nikki Hafezi is the Chief Executive Officer. Farhad Hafezi is the Chief Medical Officer of EMAGine AG, a company producing a CXL device and he is an editorial member of Eye and Vision. The other authors have no proprietary or commercial interest in any of the materials discussed in this article.
